original ) (raw )Sex- and season-dependent differences in C-peptide levels at diagnosis of immune-mediated type 1 diabetes
J. Schepper , H. Dorchy , L. Van Gaal
Diabetologia, 2006
View PDFchevron_right
Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years
M. Trovati
Diabetes Care, 1999
View PDFchevron_right
Gender differences in GAD antibody– positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases
Bengt Hallengren
Diabetes/Metabolism Research and Reviews, 2004
View PDFchevron_right
Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15- to 35-year-old diabetic subjects
Kristian Lynch
Journal of Diabetes and its Complications, 2007
View PDFchevron_right
Factors associated with preservation of C-peptide levels at the diagnosis of type 1 diabetes
Artur Bossowski
Journal of Diabetes and its Complications, 2018
View PDFchevron_right
Incidence of Type 1 and Type 2 Diabetes in Adults Aged 30-49 Years: The population-based registry in the province of Turin, Italy
Cristina Runzo , S. Pinach
Diabetes Care, 2005
View PDFchevron_right
Islet cell autoantibody levels after the diagnosis of young adult diabetic patients
Kristian Lynch
Diabetic Medicine, 2007
View PDFchevron_right
Type 1 diabetes in insulin-treated adult-onset diabetic subjects
Ian Mackay
Diabetes Research and Clinical Practice, 1998
View PDFchevron_right
Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes
Kathleen Bethin
Diabetes Care, 2014
View PDFchevron_right
Preservation of C-Peptide Levels in Children with New-Onset Type 1 Diabetes: A Comparison Based on Body Mass Index
Gulay Karaguzel
Türkiye diyabet ve obezite dergisi, 2022
View PDFchevron_right
Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry
Leonard Kaufman
Diabetes Care, 2000
View PDFchevron_right
Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: A population-based study
R. Buzzetti
Metabolism, 1998
View PDFchevron_right
Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus - a nationwide study
Jan Bolinder
Diabetic Medicine, 2000
View PDFchevron_right
Effect of Aging on A1C Levels in Individuals Without Diabetes: Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004
lisa sullivan
Diabetes Care, 2008
View PDFchevron_right
Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15?34 yrs) in the Diabetes Incidence Study in Sweden (DISS)
Lennarth Nyström
Diabetologia, 2003
View PDFchevron_right
Distribution of C-Peptide and Its Determinants in North American Children at Risk for Type 1 Diabetes
David Cuthbertson
Diabetes Care, 2014
View PDFchevron_right
Associations of age with serum insulin, proinsulin and the proinsulin-to-insulin ratio: a cross-sectional study
Trond Jenssen
BMC Endocrine Disorders, 2010
View PDFchevron_right
Relationship of C-peptide levels to duration of Type 1 diabetes – A study from Sindh, Pakistan
Nazish Waris
Pakistan Journal of Medical Sciences, 2020
View PDFchevron_right
The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence
Kathleen Gillespie
Diabetologia, 2003
View PDFchevron_right
Age-Corrected Beta Cell Mass Following Onset of Type 1 Diabetes Mellitus Correlates with Plasma C-Peptide in Humans
David Klinke
PLoS ONE, 2011
View PDFchevron_right
Assessing Age-Related Etiologic Heterogeneity in the Onset of Islet Autoimmunity
Marci Sontag
BioMed Research International, 2015
View PDFchevron_right
The Presence of GAD and IA-2 Antibodies in Youth With a Type 2 Diabetes Phenotype: Results from the TODAY study
Ruth Weinstock
Diabetes Care, 2010
View PDFchevron_right
Islet autoantibodies and residual beta cell function in type 1 diabetes children followed for 3–6 years
F. Vaziri-Sani
Diabetes Research and Clinical Practice, 2012
View PDFchevron_right
The Serum C Peptide Levels Among the Offsprings of the People with Type 2 Diabetes
Prof. (Dr.) Farhan Ahmad Khan
2013
View PDFchevron_right
Circulating C-Peptide Levels in Living Children and Young People and Pancreatic β-Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease Duration
Bethany Hull
Diabetes
View PDFchevron_right
Genetic Effects on Age-Dependent Onset and Islet Cell Autoantibody Markers in Type 1 Diabetes
Ingrid Kockum
Diabetes, 2002
View PDFchevron_right
C-peptide in the classification of diabetes in children and adolescents
Sten Ivarsson
Pediatric Diabetes, 2012
View PDFchevron_right